Pembrolizumab-induced Myositis in the Setting of Metastatic Melanoma: An Increasingly Common Phenomenon | JCAD | The Journal of Clinical and Aesthetic Dermatology

J Clin Aesthet Dermatol. 2020;13(6):44–45 by Ritu Swali, MD Dr. Swali is with the Department of Medicine, University of California, Irvine in Irvine, California. FUNDING: No funding was provided for this study. DISCLOSURES: The author has no conflicts of interest relevant to the content of this article. ABSTRACT: Pembrolizumab, an anti-programmed cell death protein 1 […]

Read the full article here

Related Articles